LLY

1,028.17

-2.17%↓

JNJ

248.62

+0.08%↑

ABBV

234.29

+0.99%↑

NVS

167.27

-0.62%↓

MRK

121.94

-1.44%↓

LLY

1,028.17

-2.17%↓

JNJ

248.62

+0.08%↑

ABBV

234.29

+0.99%↑

NVS

167.27

-0.62%↓

MRK

121.94

-1.44%↓

LLY

1,028.17

-2.17%↓

JNJ

248.62

+0.08%↑

ABBV

234.29

+0.99%↑

NVS

167.27

-0.62%↓

MRK

121.94

-1.44%↓

LLY

1,028.17

-2.17%↓

JNJ

248.62

+0.08%↑

ABBV

234.29

+0.99%↑

NVS

167.27

-0.62%↓

MRK

121.94

-1.44%↓

LLY

1,028.17

-2.17%↓

JNJ

248.62

+0.08%↑

ABBV

234.29

+0.99%↑

NVS

167.27

-0.62%↓

MRK

121.94

-1.44%↓

Начало・Списък с акции・Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

Отворен

16.12 1.13

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

15.35

Максимум

15.94

Ключови измерители
By Trading Economics
Приходи	-23M -14M
Продажби	-22M 72M
EPS	-0.09
Марж на печалбата	-18.944
Служители	619
EBITDA	-23M -6.4M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+30.21% upside

Дивиденти
By Dow Jones
Следващи печалби	30.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-441M 2.4B
Предишно отваряне	14.99
Предишно затваряне	16.12

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

8.81 / 10.18 Подкрепа & съпротива

Adaptive Biotechnologies Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.03.2026 г., 23:35 ч. UTC

Значими събития в новините

Oil Prices Jump in Asia as U.S.-Iran Conflict Stokes Supply Fears -- Energy Comment

1.03.2026 г., 23:49 ч. UTC

Пазарно говорене

Значими събития в новините

Australian Gold-Mining Stocks Rally as Attack on Iran Drives Gold Higher -- Market Talk

1.03.2026 г., 23:47 ч. UTC

Пазарно говорене

Значими събития в новините

Gold, Silver Rise as Middle East Conflict Spurs Safe-Haven Demand -- Market Talk

1.03.2026 г., 23:41 ч. UTC

Пазарно говорене

Значими събития в новините

Lasting Oil Price Shock Could Stoke Global Inflation -- Market Talk

1.03.2026 г., 23:39 ч. UTC

Пазарно говорене

Значими събития в новините

Global Equities Roundup: Market Talk

1.03.2026 г., 23:39 ч. UTC

Пазарно говорене

Значими събития в новините

Nikkei May Fall Amid Concerns About Higher Energy Prices -- Market Talk

1.03.2026 г., 23:36 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Jumps as Middle East Conflict Heightens Supply Disruption Concerns -- Market Talk

1.03.2026 г., 23:24 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

1.03.2026 г., 23:24 ч. UTC

Пазарно говорене

Financial Markets Trim Bets on RBA Hike in May -- Market Talk

1.03.2026 г., 23:21 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

1.03.2026 г., 23:21 ч. UTC

Пазарно говорене

Sky Network TV's Risk/Reward Still Not Attractive -- Market Talk

1.03.2026 г., 23:19 ч. UTC

Значими събития в новините

Front-Month Brent Crude Oil Futures Rose 8.5% to $79.08/bbl

1.03.2026 г., 23:17 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Rose 8.4% to $72.65/bbl

1.03.2026 г., 23:14 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Extend Gains in Early Trade

1.03.2026 г., 22:55 ч. UTC

Значими събития в новините

Spot Gold Rises 1.9% to $5,278.61/oz Amid Middle East Conflict

1.03.2026 г., 22:54 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Rise Amid Middle East Conflict

1.03.2026 г., 22:53 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Rise 3.2% to $67.29/bbl

1.03.2026 г., 22:38 ч. UTC

Пазарно говорене

Значими събития в новините

Attack on Iran Likely to Push Up Floor Under Gold -- Market Talk

1.03.2026 г., 22:21 ч. UTC

Печалби

Berkshire's Earnings Weren't as Bad as They Looked. A Goodwill Write-Down Hit Operating Profits. -- Barrons.com

1.03.2026 г., 22:17 ч. UTC

Пазарно говорене

Financial Markets Trim Bets On RBA Hike In May -- Market Talk

1.03.2026 г., 22:13 ч. UTC

Пазарно говорене

Значими събития в новините

OPEC+ Oil Output Boost Could Be Moot if Strait of Hormuz Unavailable -- Market Talk

1.03.2026 г., 22:00 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Could Surge Above $100 If Flows Don't Return to Normal Quickly -- Market Talk

1.03.2026 г., 21:40 ч. UTC

Пазарно говорене

Значими събития в новините

Spot Gold Up as Investors Shield Against Risk -- Market Talk

1.03.2026 г., 21:35 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Prices Seen Rising to Low to Mid-US$80s Per Barrel -- Market Talk

1.03.2026 г., 21:30 ч. UTC

Пазарно говорене

Australian Dollar Weakens Most as Trader Fear Long-Term Conflict -- Market Talk

1.03.2026 г., 21:27 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Prices Likely to Rise on Iran Conflict But to Manageable Levels -- Market Talk

1.03.2026 г., 21:19 ч. UTC

Пазарно говорене

Значими събития в новините

Shipping Disruptions 'More Acute Risk' Than Oil Output From Iran Conflict -- Market Talk

1.03.2026 г., 20:58 ч. UTC

Пазарно говорене

Значими събития в новините

Risk Off Stance in Markets Amid Fears of Wider Conflict -- Market Talk

1.03.2026 г., 20:40 ч. UTC

Пазарно говорене

Australia Dollar to Fall Sharply Against U.S. Dollar on Middle East Conflict -- Market Talk

1.03.2026 г., 20:24 ч. UTC

Пазарно говорене

Значими събития в новините

Brent Crude at $100/bbl Could Slow Pace of Global Rate Cuts -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Adaptive Biotechnologies Corp Прогноза

Ценова цел

By TipRanks

30.21% нагоре

12-месечна прогноза

Среден 20.86 USD 30.21%

Висок 22 USD

Нисък 20 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Adaptive Biotechnologies Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

Купи

Задържане

Продай

Според 8 анализатори, дали борсови рейтинги на Adaptive Biotechnologies Corp през последните 3 месеца.

Техническа оценка

By Trading Central

8.81 / 10.18Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bullish.

There is one bullish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.